DUSP1 and cardiac hypertrophy: It has been described that the methylation of the DUSP1 promoter is not associated with a decrease in its expression, suggesting the involvement of other factors in the specific repression of DUSP-1 in diabetes-associated cardiac hypertrophy [174].